Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Nordic Drugs AB

Closing information (x1000 EUR)

Closing information 2024/12 2023/12 2022/12
Turnover 31,629 Less Arrow 30,419 Less Arrow 26,965
Financial expenses 125 Less Arrow 1 More Arrow 7
Earnings before taxes 3,301 Less Arrow 1,343 Less Arrow -267
EBITDA 3,323 Less Arrow 1,271 Less Arrow -353
Total assets 16,207 Less Arrow 15,337 Less Arrow 12,499
Current assets 16,161 Less Arrow 15,238 Less Arrow 12,283
Current liabilities 4,827 More Arrow 6,078 Less Arrow 4,126
Equity capital 11,094 Less Arrow 8,823 Less Arrow 7,941
- share capital 1,741 More Arrow 1,802 Less Arrow 1,797
Employees (average) 25 Equal arrow 25 More Arrow 26

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 68.5% Less Arrow 57.5% More Arrow 63.5%
Turnover per employee 1,265 Less Arrow 1,217 Less Arrow 1,037
Profit as a percentage of turnover 10.4% Less Arrow 4.4% Less Arrow -1.0%
Return on assets (ROA) 21.1% Less Arrow 8.8% Less Arrow -2.1%
Current ratio 334.8% Less Arrow 250.7% More Arrow 297.7%
Return on equity (ROE) 29.8% Less Arrow 15.2% Less Arrow -3.4%
Change turnover 2,245 More Arrow 3,375 More Arrow 5,395
Change turnover % 8% More Arrow 12% More Arrow 25%
Chg. No. of employees 0 Less Arrow -1 More Arrow 0
Chg. No. of employees % 0% Less Arrow -4% More Arrow 0%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.